127 results
DEFA14A
RYTM
Rhythm Pharmaceuticals Inc.
26 Apr 24
Additional proxy soliciting materials
4:10pm
A. Arbuckle 02 – Christophe R. Jean 03 – Lynn A. Tetrault 2. Ratification of the appointment of Ernst & Young LLP as the independent registered public
8-K
EX-3.1
RYTM
Rhythm Pharmaceuticals Inc.
16 Apr 24
Entry into a Material Definitive Agreement
7:00am
price and the last ask price per share of Common Stock on such Trading Day from each of at least three nationally recognized independent investment
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
price per share of Common Stock on such Trading Day from each of at least three nationally recognized independent investment banking firms the Company … of similar import refer to this Agreement as a whole and not to any particular section, paragraph or subdivision.
(m) Independent Nature
S-8
RYTM
Rhythm Pharmaceuticals Inc.
29 Feb 24
Registration of securities for employees
4:58pm
& Watkins LLP
23.1*
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
23.2*
Consent of Latham & Watkins LLP (included in Exhibit 5.1
S-8
EX-23.1
8zkmde1vxd4d0x5v
29 Feb 24
Registration of securities for employees
4:58pm
424B5
pe24c1x spnl
29 Feb 24
Prospectus supplement for primary offering
4:44pm
8-K
jfsu0r3j4hn 4uyzq
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
EX-3.1
sdj8zm fgbfd
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
EX-10.1
rd6vt jdglmar
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.2
psymxtfqnwk nn
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.4
ci32eol prbhoc
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.3
4zcqfo t58
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
a37zo
22 Jun 23
Submission of Matters to a Vote of Security Holders
4:47pm